الإحصائيات الأساسية
| CIK | 1855747 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Blend Labs, Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| August 7, 2025 |
Blend Announces Second Quarter 2025 Financial Results Fourth Consecutive Quarter of YoY Revenue Growth; record RPO August 7, 2025 SAN FRANCISCO - Blend Labs, Inc. |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 7, 2025 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 7, 2025 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 7, 2025 |
Blend Announces Finance Leadership Transition Head of Blend taps Jason Ream to help lead next phase of growth and profitability August 7, 2025 at 4:05 PM EST SAN FRANCISCO - Blend Labs, Inc. |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC |
|
| June 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 11, 2025 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 9, 2025 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File Num |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 8, 2025 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, IN |
|
| May 8, 2025 |
Blend Announces First Quarter 2025 Financial Results Third Consecutive Quarter of YoY Growth Fueled by Renewed Customer Momentum May 8, 2025 •Continued execution on the strategic shift to a software-first model •Entered into an exclusive process with a leading title and mortgage services provider for potential sale of title insurance business •Platform revenue of $26. |
|
| April 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| April 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| March 14, 2025 |
Exhibit 107.1 Calculation of Filing Fee Tables FORM S-8 (Form Type) BLEND LABS, INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee (1) Equity Class A common s |
|
| March 14, 2025 |
As filed with the Securities and Exchange Commission on March 13, 2025 As filed with the Securities and Exchange Commission on March 13, 2025 Registration No. |
|
| March 13, 2025 |
Exhibit 19.1 BLEND LABS, INC. INSIDER TRADING POLICY (Revised on March 13, 2025) The Board of Directors (the “Board”) of Blend Labs, Inc. (together with its affiliates and subsidiaries, the “Company,” “we,” “our,” or “Blend”) has adopted this Insider Trading Policy (the “Policy”) in order to take an active role in the prevention of insider trading violations by our officers, directors, employees a |
|
| March 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC. (E |
|
| March 13, 2025 |
List of subsidiaries of the registrant. Exhibit 21.1 SUBSIDIARIES OF BLEND LABS, INC. Subsidiary Jurisdiction Blend Insurance Agency, Inc. Delaware Blend Operations, Inc. Delaware Blend Insights, Inc. Delaware Title365 Holding Co. California T365 Company LLC Pennsylvania Title365 Company California Title365 Signings Inc. Wyoming Title365 Company of Louisiana LLC Louisiana Title365 Company of Alabama LLC Alabama Blend Labs India Private |
|
| March 13, 2025 |
ffer Letter between the registrant and Exhibit 10.18 October 27, 2024 CONFIDENTIAL Offer Letter - Srinivasan Venkatramani Dear Srinivasan, Blend Labs, Inc. (“Blend” or the "Company") is pleased to offer you employment on the following terms: Position Your expected start date with the Company is December 2, 2024 (the actual date you begin your employment with the Company, the “Start Date”) and this letter agreement (this “Agreement”) se |
|
| March 13, 2025 |
BLEND LABS, INC. CHANGE IN CONTROL SEVERANCE AGREEMENT Exhibit 10.1 BLEND LABS, INC. CHANGE IN CONTROL SEVERANCE AGREEMENT This Change in Control Severance Agreement (the “Agreement”) is made between Blend Labs, Inc. (the “Company”) and (the “Executive”), effective as of (the “Effective Date”). This Agreement provides certain protections to the Executive in connection with a change in control of the Company or in connection with the involuntary termin |
|
| March 13, 2025 |
Exhibit 10.19 [DATE] CONFIDENTIAL [NAME] Re: Severance Benefits Dear [NAME]: This letter agreement (the “Agreement”) is entered into between [NAME] (“you”) and Blend Labs, Inc. (the “Company”) effective as of [DATE] (the “Effective Date”), to provide you certain protections in connection with the involuntary termination of your employment under the circumstances described in this Agreement. Your e |
|
| February 27, 2025 |
Blend Announces Fourth Quarter and Full Year 2024 Financial Results Welcomes Major New Customers; Achieves Strong Revenue Through Difficult Macro February 27, 2025 SAN FRANCISCO - Blend Labs, Inc. |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 27, 2025 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 10, 2025 |
Members of the GA Partnership Committee (as of the date hereof) EX-99 2 eh250585411scha.htm SCHEDULE A SCHEDULE A Members of the GA Partnership Committee (as of the date hereof) Name Address Citizenship William E. Ford (Chief Executive Officer) 55 East 52nd Street 33rd Floor New York, New York 10055 United States Gabriel Caillaux 23 Savile Row London W1S 2ET United Kingdom France Martín Escobari 55 East 52nd Street 33rd Floor New York, New York 10055 Bolivia a |
|
| November 7, 2024 |
BLND / Blend Labs, Inc. / Formation8 Partners Fund I, L.P. - SC 13G/A Passive Investment SC 13G/A 1 d838912dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Blend Labs, Inc. (Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class of Securities) 09352U108 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) |
|
| November 6, 2024 |
Blend Announces Third Quarter 2024 Financial Results Welcomes New Customers and Accomplishes Important Financial Milestones for the Business November 6, 2024 SAN FRANCISCO - Blend Labs, Inc. |
|
| November 6, 2024 |
orm of Change in Control Severance Agreement. Exhibit 10.1 BLEND LABS, INC. CHANGE IN CONTROL SEVERANCE AGREEMENT This Change in Control Severance Agreement (the “Agreement”) is made between Blend Labs, Inc. (the “Company”) and (the “Executive”), effective as of (the “Effective Date”). This Agreement provides certain protections to the Executive in connection with a change in control of the Company or in connection with the involuntary termin |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 6, 2024 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC |
|
| August 8, 2024 |
to the Company’s Form 8-K filed with the SEC on June 24, 2024) Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PERPETUAL PREFERRED STOCK, PAR VALUE $0.00001 PER SHARE, OF BLEND LABS, INC. Blend Labs, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), in accordance with the provisions of Section 103 of the Delaware General Corporation Law (as amended, supplemented or restated |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 7, 2024 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 8, 2024 |
Blend Announces Second Quarter 2024 Financial Results Meets Revenue Guidance and Outperforms Operating Loss Target in Second Quarter 2024 August 8, 2024 SAN FRANCISCO - Blend Labs, Inc. |
|
| August 8, 2024 |
ertificate of Amendment to Certificate of Exhibit 3.1 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PERPETUAL PREFERRED STOCK, PAR VALUE $0.00001 PER SHARE, OF BLEND LABS, INC. Blend Labs, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), does hereby certify as follows: FIRST: The Certificate of Designations of Series A Convertible Perpetual Preferred Stoc |
|
| June 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 18, 2024 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 24, 2024 |
Certificate of Amendment to Certificate of Designatio Exhibit 3.1 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PERPETUAL PREFERRED STOCK, PAR VALUE $0.00001 PER SHARE, OF BLEND LABS, INC. Blend Labs, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), does hereby certify as follows: FIRST: The Certificate of Designations of Series A Convertible Perpetual Preferred Stoc |
|
| June 24, 2024 |
Amended and Restated Certificate of Designations Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PERPETUAL PREFERRED STOCK, PAR VALUE $0.00001 PER SHARE, OF BLEND LABS, INC. Blend Labs, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), in accordance with the provisions of Section 103 of the Delaware General Corporation Law (as amended, supplemented or restated |
|
| June 14, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 12, 2024 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 8, 2024 |
between the registrant and Haveli Brooks Aggregator Exhibit 4.2 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT, dated as of April 29, 2024 (the “Agreement”), is entered into by and between Blend Labs, Inc., a Delaware corporation (the “Company”) and Haveli Brooks Aggregator, L.P. (the “Investor”, and together with its successor any other party that may become a party hereto pursuant to Section 9(c), collectively the “Stockholders”, and |
|
| May 8, 2024 |
Blend Announces First Quarter 2024 Financial Results Meets Revenue Guidance and Outperforms Operating Loss Target in First Quarter 2024 May 8, 2024 SAN FRANCISCO - Blend Labs, Inc. |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, IN |
|
| May 8, 2024 |
Exhibit 10.4 INVESTMENT AGREEMENT by and between BLEND LABS, INC., and HAVELI BROOKS AGGREGATOR, L.P. Dated as of April 29, 2024 TABLE OF CONTENTS PAGE Article I Definitions 1 Section I.1 Definitions 1 Article II Purchase and Sale 11 Section II.1 Purchase and Sale 11 Section II.2 Closing 11 Article III Representations and Warranties of the Company 11 Section III.1 Organization; Standing 12 Section |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 8, 2024 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 8, 2024 |
Compensation Policy, as amended. Exhibit 10.3 BLEND LABS, INC. OUTSIDE DIRECTOR COMPENSATION POLICY Originally adopted and approved June 16, 2021, effective upon the effectiveness of the registration statement relating to the Company’s initial public offering Most recently amended on April 29, 2024, with such amendment effective as of the date of the Company’s 2024 Annual Meeting of Stockholders (the “Amendment Effective Date”) B |
|
| May 8, 2024 |
Class A Common Stock between the registrant and Haveli Brooks Aggregator, L.P., dated as of April 2 Exhibit 4.1 THE OFFER AND SALE OF THIS WARRANT AND THE SHARES OF CLASS A COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE ACT, OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF SECTIONS 6 AND 7 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE |
|
| May 8, 2024 |
Eric Woersching, dated as of April 26, 202 Exhibit 10.2 BLEND LABS, INC. April 26, 2024 Eric Woersching Re: Board of Directors of Blend Labs, Inc. Dear Eric: On behalf of Blend Labs, Inc. (“Blend” or the “Company”), we would like to extend the invitation to you to join the Company’s Board of Directors (the “Board”). Once you accept this invitation, we anticipate the Board moving quickly to formally appoint you as a member of the Board. As |
|
| May 8, 2024 |
ffer Letter between the registrant and Bryan Sullivan, dated as of April 26, 2024. Exhibit 10.1 BLEND LABS, INC. April 26, 2024 Bryan Sullivan Re: Board of Directors of Blend Labs, Inc. Dear Bryan: On behalf of Blend Labs, Inc. (“Blend” or the “Company”), we would like to extend the invitation to you to join the Company’s Board of Directors (the “Board”). Once you accept this invitation, we anticipate the Board moving quickly to formally appoint you as a member of the Board. As |
|
| May 8, 2024 |
Exhibit 3.1 CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PERPETUAL PREFERRED STOCK, PAR VALUE $0.00001 PER SHARE, OF BLEND LABS, INC. Pursuant to Section 151 of the Delaware General Corporation Law (as amended, supplemented or restated from time to time, the “DGCL”), Blend Labs, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), in accordance |
|
| May 6, 2024 |
BLND / Blend Labs, Inc. / Haveli Investments, L.P. - SC 13D Activist Investment SC 13D 1 d835249dsc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Blend Labs, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 09352U108 (CUSIP Number) Della P. Richardson Chief Compliance Officer and Deputy General Counsel Haveli Investments, L.P. 405 Colorado |
|
| May 6, 2024 |
EX-99.1 2 d835249dex991.htm EX-99.1 Exhibit 1 JOINT FILING AGREEMENT The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to such statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersign |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| April 29, 2024 |
CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PERPETUAL PREFERRED STOCK, PAR VALUE $0. |
|
| April 29, 2024 |
Warrant by and between Blend Labs, Inc. and Execution Version THE OFFER AND SALE OF THIS WARRANT AND THE SHARES OF CLASS A COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE ACT, OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF SECTIONS 6 AND 7 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE ISSUER OF THIS WARRANT, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS EXEMPT FROM REGISTRATION. |
|
| April 29, 2024 |
Registration Rights Agreement by and between Blend Labs, Inc. and Execution Version REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT, dated as of April 29, 2024 (the “Agreement”), is entered into by and between Blend Labs, Inc. |
|
| April 29, 2024 |
Blend Labs Announces Strategic Partnership with Haveli Investments, including $150 Million Investment Brian Sheth, Haveli’s Chief Investment Officer, to Join Blend’s Board April 29, 2024 4:05 PM Eastern Standard Time SAN FRANCISCO-(BUSINESS WIRE)-Blend Labs, Inc. |
|
| April 29, 2024 |
, 2024, by and between Blend Labs, Inc. and Execution Version INVESTMENT AGREEMENT by and between BLEND LABS, INC., and HAVELI BROOKS AGGREGATOR, L.P. Dated as of April 29, 2024 Active.39812068.12 TABLE OF CONTENTS PAGE Article I Definitions........................................................................................................................ 1 Section 1.01 Definitions........................................................ |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 23, 2024 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File N |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| March 15, 2024 |
Blend Announces Fourth Quarter and Full Year 2023 Financial Results Meets Fourth Quarter 2023 Revenue Guidance and Delivers Strong Operating Loss Improvement in Every Quarter in 2023 March 15, 2024 No changes to previously reported GAAP financial measures. |
|
| March 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 14, 2024 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) |
|
| March 14, 2024 |
Exhibit 107.1 Calculation of Filing Fee Tables FORM S-8 (Form Type) BLEND LABS, INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A common stock, |
|
| March 14, 2024 |
Exhibit 21.1 SUBSIDIARIES OF BLEND LABS, INC. Subsidiary Jurisdiction Blend Brokerage, Inc. dba Blend Realty Delaware Blend Title Insurance Agency, Inc. Delaware Blend Insurance Agency, Inc. Delaware Blend Operations, Inc. Delaware Blend Insights, Inc. Delaware Blend Title of Utah, LLC Utah Title365 Holding Co. California T365 Company LLC Pennsylvania Title365 Company California Title365 Signings |
|
| March 14, 2024 |
Blend Labs, Inc. 2021 Equity Incentive Plan and related form agreements. Exhibit 10.2 BLEND LABS, INC. 2021 EQUITY INCENTIVE PLAN 1.Purposes of the Plan; Award Types. (a)Purposes of the Plan. The purposes of this Plan are to attract and retain personnel for positions with the Company Group, to provide additional incentive to Employees, Directors, and Consultants (collectively, “Service Providers”), and to promote the success of the Company’s business. (b)Award Types. T |
|
| March 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC. (E |
|
| March 14, 2024 |
As filed with the Securities and Exchange Commission on March 14, 2024 S-8 1 d803774ds8.htm S-8 As filed with the Securities and Exchange Commission on March 14, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BLEND LABS, INC. (Exact name of registrant as specified in its charter) Delaware 45-5211045 (State or other jurisdiction of incorporation or |
|
| March 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 14, 2024 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File N |
|
| March 14, 2024 |
BLEND LABS, INC. COMPENSATION RECOVERY POLICY As adopted on November 22, 2023 Blend Labs, Inc. (the “Company”) is committed to strong corporate governance. As part of this commitment, the Company’s Board of Directors (the “Board”) has adopted this Compensation Recovery Policy (the “Policy”). The Policy is intended to further the Company’s pay-for-performance philosophy and to comply with applicabl |
|
| March 14, 2024 |
EXECUTION VERSION STOCKHOLDERS AGREEMENT OF TITLE365 HOLDING CO. This STOCKHOLDERS AGREEMENT (this “Agreement”), dated as of June 30, 2021, is entered into by and among Title365 Holding Co., a California corporation (the “Company”), Blend Labs, Inc., a Delaware corporation (“Blend”), and Xome Holdings LLC., a Delaware limited liability company (“Mr. Cooper”). RECITALS WHEREAS, pursuant to that cer |
|
| March 14, 2024 |
Blend Announces Fourth Quarter and Full Year 2023 Financial Results Meets Fourth Quarter 2023 Revenue Guidance and Delivers Strong Operating Loss Improvement in Every Quarter in 2023 March 14, 2024 SAN FRANCISCO - Blend Labs, Inc. |
|
| February 13, 2024 |
BLND / Blend Labs, Inc. / Ghamsari Nima - SC 13G/A Passive Investment SC 13G/A 1 d743744dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* BLEND LABS, INC. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 09352U108 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| February 13, 2024 |
BLND / Blend Labs, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0446-blendlabsincclassa.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Blend Labs, Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 09352U108 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to d |
|
| February 13, 2024 |
BLND / Blend Labs, Inc. / GENERAL ATLANTIC LLC - AMENDMENT NO. 1 Passive Investment SC 13G/A 1 eh24044745713ga1-blend.htm AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Blend Labs, Inc. (Name of Issuer) Class A common stock, par value $0.00001 per share (Title of Class of Securities) 09352U108 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of t |
|
| February 6, 2024 |
BLND / Blend Labs, Inc. / Temasek Holdings (Private) Ltd - SC 13G/A Passive Investment SC 13G/A 1 d737393dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Blend Labs, Inc. (Name of Issuer) Class A common stock, par value $0.00001 |
|
| November 28, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 27, 2023 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission Fil |
|
| November 28, 2023 |
SECOND AMENDMENT TO CREDIT AGREEMENT This SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is entered into as of November 27, 2023, by and among Blend Labs, Inc. |
|
| November 7, 2023 |
Exhibit 10.1 Nima Ghamsari August 25, 2023 Dear Nima, We appreciate the impact you have had at Blend (“Blend” or “the Company”). Based on a recommendation of the Compensation Committee of the Company’s Board of Directors (the “Board”), the Board has adjusted your compensation in accordance with the terms of this letter agreement (the “Agreement”). Base Salary Your annual base salary was increased |
|
| November 7, 2023 |
Exhibit 10.2 BLEND LABS, INC. CHANGE IN CONTROL SEVERANCE AGREEMENT This Change in Control Severance Agreement (the “Agreement”) is made between Blend Labs, Inc. (the “Company”) and (the “Executive”), effective as of (the “Effective Date”). This Agreement provides certain protections to the Executive in connection with a change in control of the Company or in connection with the involuntary termin |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 7, 2023 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS |
|
| November 7, 2023 |
Blend Announces Third Quarter 2023 Financial Results Third Quarter Results Meet Revenue and Operating Loss Targets for Third Consecutive Quarter November 7, 2023 SAN FRANCISCO - Blend Labs, Inc. |
|
| November 7, 2023 |
Exhibit 10.3 Name: Date: Dear , We appreciate the impact you have had at Blend (“Blend” or “the Company”). I will recommend to the Company’s Board of Directors or its designated committee (the Board of Directors or its designated committee, together, the “Committee”), [that your compensation be adjusted], [and] [that you be granted certain awards,] in accordance with the terms of this letter agree |
|
| September 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 25, 2023 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission Fi |
|
| August 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 23, 2023 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 9, 2023 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 9, 2023 |
Blend Announces Second Quarter 2023 Financial Results Second Quarter Results Exceed Guidance on Revenue and Non-GAAP Operating Loss; Accelerates Path to Profitability August 9, 2023 SAN FRANCISCO - Blend Labs, Inc. |
|
| June 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 15, 2023 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 9, 2023 |
Blend Announces First Quarter 2023 Financial Results First Quarter Results Exceed Guidance on Mortgage Origination Outperformance; Gross Margins and Operating Performance Improve May 9, 2023 SAN FRANCISCO - Blend Labs, Inc. |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 4, 2023 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, IN |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 28, 2023 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 4, 2023 |
Blend Receives Continued Listing Standard Notice from NYSE May 4, 2023 - Blend Labs, Inc. |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| April 6, 2023 |
Letter from Ernst & Young LLP to the Securities and Exchange Commission dated April 6, 2023. April 6, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated April 6, 2023, of Blend, Labs, Inc. and are in agreement with the statements contained in the second, third, and fourth paragraphs on page 2 therein. Regarding the registrant's statement concerning the lack of internal control to prepare financial |
|
| April 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 5, 2023 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| March 16, 2023 |
List of subsidiaries of the Registrant. Exhibit 21.1 SUBSIDIARIES OF BLEND LABS, INC. Subsidiary Jurisdiction Blend Brokerage, Inc. dba Blend Realty Delaware Blend Title Insurance Agency, Inc. Delaware Blend Insurance Agency, Inc. Delaware Blend Operations, Inc. Delaware Blend Insights, Inc. Delaware Blend Title of Utah, LLC Utah Blend Processing, Inc. Delaware Blend Managing General Insurance Agency, Inc. Delaware Title365 Holding Co. |
|
| March 16, 2023 |
Outside Director Compensation Policy. OUTSIDE DIRECTOR COMPENSATION POLICY Originally adopted and approved June 16, 2021, effective upon the effectiveness of the registration statement relating to the Company’s initial public offering (the “Effective Date”) Most recently amended on January 10, 2023, with such amendment effective January 1, 2023 (the “Amendment Effective Date”) Blend Labs, Inc. |
|
| March 16, 2023 |
between the registrant and Crystal Sumner, dated as of Transition Agreement and General Release February 1, 2023 Dear Crystal Sumner: This Transition Agreement and Release (the “Agreement”) sets forth the agreement between you and Blend Labs, Inc. |
|
| March 16, 2023 |
Name: Marc Greenberg Date: 01/09/2023 Dear Marc, In recognition of your contributions to Blend Labs, Inc. |
|
| March 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 16, 2023 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File N |
|
| March 16, 2023 |
amendment-creditagreemen EXECUTION VERSION US-DOCS\133960080.4 FIRST AMENDMENT TO CREDIT AGREEMENT This FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is entered into as of October 18, 2022, by and among Blend Labs, Inc., as Borrower (in such capacity, the “Borrower”), each of the Guarantors party hereto, and Owl Rock Technology Finance Corp. (“Owl Rock”), as Administrative Agent for the L |
|
| March 16, 2023 |
Offer Letter between the registrant and Erin Lantz, dated as of January 5, 2023. BLEND LABS, INC. January 5, 2023 Erin Lantz Re: Board of Directors of Blend Labs, Inc. Dear Erin: On behalf of Blend Labs, Inc. (“Blend” or the “Company”), we would like to extend the invitation to you to join the Company’s Board of Directors (the “Board”). Once you accept this invitation, we anticipate the Board moving quickly to formally appoint you as a member of the Board. As you may be aware, |
|
| March 16, 2023 |
Offer Letter between the registrant and Amir Jafari, dated as of January 9, 2023. Offer Letter January 9, 2023 Dear Amir Jafari, Blend Labs, Inc. (“Blend” or the "Company") is pleased to offer you employment on the following terms: Position Your initial role will be Head of Finance and Administration. Your anticipated start date is January 30, 2023 (the date you actually commence employment with the Company, the “Start Date”). This is a full-time position. While you render serv |
|
| March 16, 2023 |
Blend Announces Fourth Quarter and Full Year 2022 Financial Results Blend delivers on 2022 total company revenue guidance amidst challenging economic conditions March 16, 2023 SAN FRANCISCO - Blend Labs, Inc. |
|
| March 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC. (E |
|
| March 16, 2023 |
Exhibit 107.1 Calculation of Filing Fee Tables FORM S-8 (Form Type) BLEND LABS, INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A common stock, |
|
| March 16, 2023 |
As filed with the Securities and Exchange Commission on March 16, 2023 S-8 As filed with the Securities and Exchange Commission on March 16, 2023 Registration No. |
|
| February 14, 2023 |
BLND / Blend Labs, Inc. / Ghamsari Nima - SC 13G/A Passive Investment SC 13G/A 1 d428747dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* BLEND LABS, INC. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 09352U108 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| February 14, 2023 |
BLND / Blend Labs, Inc. / TIGER GLOBAL MANAGEMENT LLC Passive Investment SC 13G/A 1 d993413713g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Blend Labs, Inc. (Name of Issuer) Class A Common Stock, par value $0.00001 per share (Title of Class of Securities) 09352U108 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the ap |
|
| February 14, 2023 |
BLND / Blend Labs, Inc. / Lightspeed Venture Partners IX, L.P. - SC 13G/A Passive Investment SC 13G/A 1 tm235421d3sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Blend Labs, Inc. (Name of Issuer) Class A common stock, par value $0.00001 per share (Title of Class of Securities) 09352U108 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement |
|
| February 9, 2023 |
BLND / Blend Labs, Inc. / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SC 13G 1 tv0425-blendlabsincclassa.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Blend Labs Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 09352U108 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuan |
|
| February 8, 2023 |
BLND / Blend Labs, Inc. / 8VC Co-Invest Fund I, L.P. - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Blend Labs, Inc. (Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class of Securities) 09352U108 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to d |
|
| January 10, 2023 |
BLEND ANNOUNCES STRATEGIC AND FINANCIAL INITIATIVES TO ACHIEVE PATH TO PROFITABILITY Total cost reductions expected to deliver cumulative savings of over $100 million by end of 2023 relative to Q3 2022 when fully implemented Elevation of Blend Builder enhances revenue generation and margin profile with platform-as-a-service component Leadership appointments highlight Blend’s transition to a platform company January 10, 2023 SAN FRANCISCO-(BUSINESS WIRE)- Blend (NYSE: BLND) announced today a series of specific initiatives that support its previously communicated plan to accelerate its path to profitability. |
|
| January 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 9, 2023 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File |
|
| November 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS |
|
| November 10, 2022 |
Blend Announces Third Quarter 2022 Financial Results Total revenue of $55.4 million led by Platform revenue resilience, offset by lower Title365 revenue November 10, 2022 SAN FRANCISCO - (BUSINESS WIRE) - Blend Labs, Inc. (NYSE:BLND), a leader in cloud banking software, today announced its third quarter 2022 financial results. “Blend’s third quarter results reflect steady progress, including impor |
|
| November 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 9, 2022 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File |
|
| August 15, 2022 |
EX-99.1 2 exhibit991q22022xpressrel.htm EX-99.1 Blend Announces Second Quarter 2022 Financial Results Total revenue of $65.5 million led by Mortgage Banking outperformance and Consumer Banking and Marketplace growth, offset by lower Title365 revenue August 15, 2022 SAN FRANCISCO - (BUSINESS WIRE) - Blend Labs, Inc. (NYSE:BLND), a leader in cloud banking software, today announced its second quarter |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 11, 2022 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File |
|
| June 29, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 28, 2022 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 19, 2022 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File Num |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, IN |
|
| May 12, 2022 |
Blend Announces First Quarter 2022 Financial Results Consolidated revenue of $71.5 million includes solid Blend Platform growth in declining U.S. mortgage market Blend maintains 2022 revenue outlook May 12, 2022 SAN FRANCISCO - (BUSINESS WIRE) - Blend Labs, Inc. (NYSE:BLND), a leader in cloud banking software, today announced its first quarter 2022 financial results. ?Blend?s first quarter reflect |
|
| May 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 12, 2022 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File Num |
|
| May 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 DEF 14A 1 blendlabsinc-proxy2022.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted |
|
| May 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| April 19, 2022 |
Regulation FD Disclosure, Costs Associated with Exit or Disposal Activities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 18, 2022 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File N |
|
| March 31, 2022 |
Blend Labs, Inc. 2021 Equity Incentive Plan and related form agreements. Exhibit 10.2 BLEND LABS, INC. 2021 EQUITY INCENTIVE PLAN 1.Purposes of the Plan; Award Types. (a)Purposes of the Plan. The purposes of this Plan are to attract and retain personnel for positions with the Company Group, to provide additional incentive to Employees, Directors, and Consultants (collectively, ?Service Providers?), and to promote the success of the Company?s business. (b)Award Types. T |
|
| March 31, 2022 |
List of subsidiaries of the Registrant Exhibit 21.1 SUBSIDIARIES OF BLEND LABS, INC. Subsidiary Jurisdiction Blend Brokerage, Inc. dba Blend Realty Delaware Blend Title Insurance Agency, Inc. Delaware Blend Insurance Agency, Inc. Delaware Blend Operations, Inc. Delaware Blend Insights, Inc. Delaware Blend Title of Utah, LLC Utah Blend Processing, Inc. Delaware Blend Managing General Insurance Agency, Inc. Delaware Title365 Holding Co. |
|
| March 31, 2022 |
Offer Letter between the registrant and Ciara Burnham, dated as of December 7, 2021. Exhibit 10.17 BLEND LABS, INC. December 7, 2021 Ciara Burnham Re: Board of Directors of Blend Labs, Inc. Dear Ciara: On behalf of Blend Labs, Inc. (?Blend? or the ?Company?), we would like to extend the invitation to you to join the Company?s Board of Directors (the ?Board?). Once you accept this invitation, we anticipate the Board moving quickly to formally appoint you as a member of the Board. A |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC. (E |
|
| March 31, 2022 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-8 (Form Type) BLEND LABS, INC. |
|
| March 31, 2022 |
As filed with the Securities and Exchange Commission on March 31, 2022 As filed with the Securities and Exchange Commission on March 31, 2022 Registration No. |
|
| March 31, 2022 |
Blend Announces Fourth Quarter and Full Year 2021 Financial Results Fourth Quarter Revenue Growth Driven by Blend Platform Segment Full Year 2022 Revenue Guidance Reflects Expected 35% Mortgage Industry Volume Decline from Full Year 2021 Level March 31, 2022 SAN FRANCISCO-(BUSINESS WIRE)- Blend Labs, Inc. |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 31, 2022 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File N |
|
| March 31, 2022 |
EX-4.4 2 q42021-exhibit44.htm EX-4.4 Exhibit 4.4 DESCRIPTION OF CAPITAL STOCK General The following description summarizes certain important terms of the capital stock of Blend Labs, Inc. ("us," "our," "we," or the "Company") capital stock and certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws as currently in effect. Because it is only a sum |
|
| February 14, 2022 |
BLND / Blend Labs, Inc. / Temasek Holdings (Private) Ltd - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Blend Labs, Inc. (Name of Issuer) Class A common stock, par value $0.00001 per share (Title of Class of Securities |
|
| February 14, 2022 |
Exhibit 1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. |
|
| February 14, 2022 |
BLND / Blend Labs, Inc. / 8VC Co-Invest Fund I, L.P. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Blend Labs, Inc. (Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class of Securities) 09352U108 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| February 14, 2022 |
BLND / Blend Labs, Inc. / COATUE MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 14, 2022 |
Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G, dated February 14, 2022 (the ?Schedule 13G?), with respect to the Class A common stock, par value $0.00001 per share, of Blend Labs, Inc. is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)( |
|
| February 14, 2022 |
BLND / Blend Labs, Inc. / TIGER GLOBAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 14, 2022 |
BLND / Blend Labs, Inc. / Mhatre Ravi - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Blend Labs, Inc. (Name of Issuer) Class A common stock, par value $0.00001 per share (Title of Class of Securities) 09352U108 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| February 14, 2022 |
BLND / Blend Labs, Inc. / Formation8 Partners Fund I, L.P. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Blend Labs, Inc. (Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class of Securities) 09352U108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| February 14, 2022 |
BLND / Blend Labs, Inc. / Ghamsari Nima - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 * BLEND LABS, INC. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 09352U108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil |
|
| February 14, 2022 |
BLND / Blend Labs, Inc. / COATUE MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 14, 2022 |
Exhibit 1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. |
|
| December 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 11, 2021 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission Fil |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS |
|
| November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 10, 2021 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission Fil |
|
| November 10, 2021 |
Blend Reports Third Quarter 2021 Financial Results Blend Platform segment achieves strong revenue growth driven by high retention, deepening of customer relationships and new logo wins; Raises full year 2021 revenue guidance midpoint by $13 million November 10, 2021 SAN FRANCISCO-(BUSINESS WIRE)-Blend Labs, Inc. |
|
| August 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-40599 BLEND LABS, INC |
|
| August 24, 2021 |
Amended and Restated Certificate of Incorporation of the Registrant. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF BLEND LABS, INC. Blend Labs, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the ?Delaware General Corporation Law?), DOES HEREBY CERTIFY: FIRST: That the name of this corporation is Blend Labs, Inc. (the ?Corporation?) and that the Corporation |
|
| August 24, 2021 |
Amended and Restated Bylaws of the registrant. Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF BLEND LABS INC. (adopted on June 29, 2021) (Effective upon the closing of the Company?s initial public offering) TABLE OF CONTENTS Page ARTICLE I - CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 1.2 OTHER OFFICES 1 ARTICLE II - MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 2.3 SPECIAL MEETING 1 2.4 ADVANCE NOTICE PROCEDURES 2 2.5 NO |
|
| August 24, 2021 |
Exhibit 10.12 BLEND LABS, INC. STAND-ALONE STOCK OPTION AGREEMENT I.NOTICE OF STOCK OPTION GRANT Name: Nima Ghamsari Address: The undersigned Participant has been granted a Nonstatutory Stock Option to purchase Common Stock of the Company, subject to the terms and conditions of this Stand-Alone Stock Option Agreement (the ?Option Agreement?), as follows: Date of Grant: March 31, 2021 Exercise Pric |
|
| August 19, 2021 |
Blend Reports Second Quarter 2021 Financial Results EX-99.1 2 exhibit991q22021xpressrel.htm EX-99.1 Blend Reports Second Quarter 2021 Financial Results SAN FRANCISCO, Aug. 19, 2021 - Blend Labs, Inc. (NYSE:BLND), a leader in cloud banking software, today announced financial results for the second quarter ended June 30, 2021. Second Quarter Financial Highlights •Revenue of $32.1 million, up $10.1 million, or 46% year-over-year •Loss from operations |
|
| August 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 19, 2021 Blend Labs, Inc. (Exact name of Registrant, as specified in its charter) Delaware 001-40599 45-5211045 (State or other jurisdiction of incorporation) (Commission File |
|
| July 30, 2021 |
BLND / Blend Labs, Inc. / TIGER GLOBAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| July 29, 2021 |
BLND / Blend Labs, Inc. / GENERAL ATLANTIC LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Blend Labs, Inc. (Name of Issuer) Class A common stock, par value $0.00001 per share (Title of Class of Securities) 09352U108 (CUSIP Number) July 20, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| July 22, 2021 |
BLND / Blend Labs, Inc. / COATUE MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| July 16, 2021 |
As filed with the Securities and Exchange Commission on July 16, 2021 As filed with the Securities and Exchange Commission on July 16, 2021 Registration No. |
|
| July 16, 2021 |
Table of Contents Filed pursuant to Rule 424(b)(4) Registration No. 333-257223 Class A Common Stock 20,000,000 Shares This is an initial public offering of shares of Class A common stock of Blend Labs, Inc. Prior to this offering, there has been no public market for our Class A common stock. The initial public offering price per share is $18.00. We have been approved to list our Class A common sto |
|
| July 13, 2021 |
July 13, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, N.E. Washington, D.C. 20549 Attention: Anna Abramson Jeff Kauten Melissa Kindelan Christine Dietz Re: Blend Labs, Inc. Registration Statement on Form S-1 File No. 333-257223 Acceleration Request Requested Date: July 15, 2021 Requested Time: 4:00 P.M. Eastern Time Ladie |
|
| July 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Blend Labs, Inc. (Exact name of registrant as specified in its charter) Delaware 45-5211045 (State of incorporation or organization) (I.R.S. Employer Identification No.) 415 Kearny Street San Franc |
|
| July 13, 2021 |
July 13, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, N.E. Washington, D.C. 20549 Attention: Anna Abramson Jeff Kauten Melissa Kindelan Christine Dietz Re: Blend Labs, Inc. Registration Statement on Form S-1 File No. 333-257223 Acceleration Request Requested Date: July 15, 2021 Requested Time: 4:00 P.M. Eastern Time Ladie |
|
| July 6, 2021 |
Exhibit 10.14 BLEND LABS, INC. STAND-ALONE STOCK OPTION AGREEMENT I. NOTICE OF STOCK OPTION GRANT Name: Nima Ghamsari Address: The undersigned Participant has been granted a Nonstatutory Stock Option to purchase Common Stock of the Company, subject to the terms and conditions of this Stand-Alone Stock Option Agreement (the ?Option Agreement?), as follows: Date of Grant: March 31, 2021 Exercise Pri |
|
| July 6, 2021 |
Blend Labs, Inc. 2021 Equity Incentive Plan and related form agreements. Exhibit 10.2 BLEND LABS, INC. 2021 EQUITY INCENTIVE PLAN 1. Purposes of the Plan; Award Types. (a) Purposes of the Plan. The purposes of this Plan are to attract and retain personnel for positions with the Company Group, to provide additional incentive to Employees, Directors, and Consultants (collectively, ?Service Providers?), and to promote the success of the Company?s business. (b) Award Types |
|
| July 6, 2021 |
Exhibit 10.18 CREDIT AGREEMENT dated as of June 30, 2021 among BLEND LABS, INC, as Borrower, THE GUARANTORS FROM TIME TO TIME PARTY HERETO, THE LENDERS FROM TIME TO TIME PARTY HERETO, OWL ROCK TECHNOLOGY FINANCE CORP., as Administrative Agent and Collateral Agent OWL ROCK TECHNOLOGY ADVISORS LLC, as Lead Arranger and Bookrunner, and OR TECH LENDING LLC, OR LENDING LLC, and ORO BL LLC, as Co-Syndic |
|
| July 6, 2021 |
Form of Underwriting Agreement. Exhibit 1.1 Blend Labs, Inc. Common Stock Underwriting Agreement , 2021 Goldman Sachs & Co. LLC, Allen & Company LLC As representatives (the ?Representatives?) of the several Underwriters named in Schedule I hereto, c/o Goldman Sachs & Co. LLC, 200 West Street, New York, New York 10282-2198 c/o Allen & Company LLC, 711 Fifth Avenue, New York, New York 10022 Ladies and Gentlemen: Blend Labs, Inc., |
|
| July 6, 2021 |
List of subsidiaries of the registrant. Exhibit 21.1 SUBSIDIARIES OF BLEND LABS, INC. Subsidiary Jurisdiction Blend Brokerage, Inc. dba Blend Realty Delaware Blend Title Insurance Agency, Inc. Delaware Blend Insurance Agency, Inc. Delaware Blend Operations, Inc. Delaware Blend Insights, Inc. Delaware Blend Title of Utah, LLC Utah Blend Title Company, Inc. California Title365 Holding Co. T365 Company LLC T365 Company Title365 Signings In |
|
| July 6, 2021 |
Form of Class A common stock certificate of the Registrant. EX-4.1 6 d162671dex41.htm EX-4.1 Exhibit 4.1 ZQ|CERT#|COY|CLS|RGSTRY|ACCT#|TRANSTYPE|RUN#|TRANS# Class A Common Stock Class A Common Stock PO PAR VALUE $.01 MR ADD ADD ADD ADD 43 2 1 A BOX DESIGNATION SAMPLE Certificate Shares 505006, Number * * 000000 ****************** (IF * * * 000000 ***************** ANY) ZQ00000000 **** 000000 **************** Louisville, BLEND LABS, INC. ***** 000000 ****** |
|
| July 6, 2021 |
As filed with the Securities and Exchange Commission on July 6, 2021. Table of Contents As filed with the Securities and Exchange Commission on July 6, 2021. |
|
| July 6, 2021 |
Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF BLEND LABS, INC. Blend Labs, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify that: 1. The name of this corporation is Blend Labs, Inc. 2. The Certificate of Incorporation of this corporation was originally filed with the Secretary of State of |
|
| July 6, 2021 |
Exhibit 10.9 July 1, 2021 CONFIDENTIAL Tim Mayopoulos Re: Confirmatory Employment Letter Dear Tim Mayopoulos: This letter agreement (the ?Agreement?) is entered into between Tim Mayopoulos (?you?) and Blend Labs, Inc. (the ?Company?) effective as of July 1, 2021 (the ?Effective Date?), to confirm the terms and conditions of your employment with the Company as of the Effective Date. This Agreement |
|
| July 6, 2021 |
Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF BLEND LABS, INC. Blend Labs, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the ?Delaware General Corporation Law?), DOES HEREBY CERTIFY: FIRST: That the name of this corporation is Blend Labs, Inc. (the ?Corporation?) and that the Corporation |
|
| July 6, 2021 |
Confirmatory Employment Letter between the registrant and Nima Ghamsari, dated as of July 1, 2021. Exhibit 10.8 July 1, 2021 CONFIDENTIAL Nima Ghamsari Re: Confirmatory Employment Letter Dear Nima Ghamsari: This letter agreement (the ?Agreement?) is entered into between Nima Ghamsari (?you?) and Blend Labs, Inc. (the ?Company?) effective as of July 1, 2021 (the ?Effective Date?), to confirm the terms and conditions of your employment with the Company as of the Effective Date. Except as provided |
|
| July 6, 2021 |
Confirmatory Employment Letter between the registrant and Crystal Sumner, dated as of June 29, 2021. Exhibit 10.10 June 29, 2021 CONFIDENTIAL Crystal Sumner Re: Confirmatory Employment Letter Dear Crystal Sumner: This letter agreement (the ?Agreement?) is entered into between Crystal Sumner (?you?) and Blend Labs, Inc. (the ?Company?) effective as of June 29, 2021 (the ?Effective Date?), to confirm the terms and conditions of your employment with the Company as of the Effective Date. This Agreeme |
|
| July 6, 2021 |
Exhibit 3.4 AMENDED AND RESTATED BYLAWS OF BLEND LABS INC. (adopted on July , 2021) (Effective upon the closing of the Company?s initial public offering) TABLE OF CONTENTS Page ARTICLE I - CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 1.2 OTHER OFFICES 1 ARTICLE II - MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 2.3 SPECIAL MEETING 1 2.4 ADVANCE NOTICE PROCEDURES 2 2.5 NOTI |
|
| July 6, 2021 |
Form of Equity Exchange Agreement between the registrant and Nima Ghamsari. Exhibit 10.16 EQUITY EXCHANGE RIGHT AGREEMENT THIS EQUITY EXCHANGE RIGHT AGREEMENT (this ?Agreement?) is made and entered into as of July , 2021, by and between Blend Labs Inc., a Delaware corporation (the ?Company?), and Nima Ghamsari (the ?Executive?). WHEREAS, the Company?s board of directors (the ?Board?) has determined that it is in the best interests of the Company and its stockholders to im |
|
| July 6, 2021 |
Form of Exchange Agreement between the registrant and Nima Ghamsari. EX-10.15 18 d162671dex1015.htm EX-10.15 Exhibit 10.15 EXCHANGE AGREEMENT THIS EXCHANGE AGREEMENT (this “Agreement”) is made and entered into as of July , 2021, by and between Blend Labs Inc., a Delaware corporation (the “Company”), and stockholders of the Company listed on Schedule A hereto (collectively, “Exchange Stockholders”). WHEREAS, the Company’s board of directors (the “Board”) has determi |
|
| July 6, 2021 |
Confirmatory Employment Letter between the registrant and Marc Greenberg, dated as of June 29, 2021. EX-10.11 16 d162671dex1011.htm EX-10.11 Exhibit 10.11 June 29, 2021 CONFIDENTIAL Marc Greenberg Re: Confirmatory Employment Letter Dear Marc Greenberg: This letter agreement (the “Agreement”) is entered into between Marc Greenberg (“you”) and Blend Labs, Inc. (the “Company”) effective as of June 29, 2021 (the “Effective Date”), to confirm the terms and conditions of your employment with the Compan |
|
| July 6, 2021 |
Exhibit 4.4 THIS WARRANT AND THE SHARES OF STOCK THAT MAY BE PURCHASED UPON THE EXERCISE OF THIS WARRANT HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT FOR DISTRIBUTION, AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?). SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED OR HYPOTHECATED, OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTRATION UNDER THE ACT OR |
|
| July 6, 2021 |
Exhibit 4.3 THIS WARRANT AND THE SHARES OF STOCK THAT MAY BE PURCHASED UPON THE EXERCISE OF THIS WARRANT HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT FOR DISTRIBUTION, AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?). SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED OR HYPOTHECATED, OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTRATION UNDER THE ACT OR |
|
| July 6, 2021 |
EX-10.1 10 d162671dex101.htm EX-10.1 Exhibit 10.1 BLEND LABS, INC. INDEMNIFICATION AGREEMENT This Indemnification Agreement (this “Agreement”) is dated as of [insert date], and is between Blend Labs, Inc., a Delaware corporation (together with its subsidiaries, the “Company”), and [insert name] (“Indemnitee”). RECITALS A. Indemnitee’s service to the Company substantially benefits the Company. B. I |
|
| July 6, 2021 |
Form of Change in Control Severance Agreement. Exhibit 10.6 BLEND LABS, INC. CHANGE IN CONTROL SEVERANCE AGREEMENT This Change in Control Severance Agreement (the ?Agreement?) is made between Blend Labs, Inc. (the ?Company?) and (the ?Executive?), effective as of , 2021 (the ?Effective Date?). This Agreement provides certain protections to the Executive in connection with a change in control of the Company or in connection with the involuntary |
|
| June 25, 2021 |
Wilson Sonsini Goodrich & Rosati Professional Corporation 650 Page Mill Road Palo Alto, California 94304-1050 O: 650. |
|
| June 21, 2021 |
Executive Incentive Compensation Plan. Exhibit 10.5 BLEND LABS, INC. EXECUTIVE INCENTIVE COMPENSATION PLAN 1. Purposes of the Plan. The Plan is intended to increase stockholder value and the success of the Company by motivating Employees to (a) perform to the best of their abilities and (b) achieve the Company?s objectives. 2. Definitions. 2.1 ?Actual Award? means as to any Performance Period, the actual award (if any) payable to a Par |
|
| June 21, 2021 |
EX-4.2 4 d162671dex42.htm EX-4.2 Exhibit 4.2 BLEND LABS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT JANUARY 11, 2021 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT This AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of the 11 day of January, 2021, by and among BLEND LABS, INC., a Delaware corporation (the “Company”), and the investors listed on Schedule |
|
| June 21, 2021 |
Offer Letter between the registrant and Erin Collard, dated as of March 29, 2021. Exhibit 10.12 BLEND LABS, INC. March 29, 2021 Erin Collard Re: Board of Directors of Blend Labs, Inc. Dear Erin: The purpose of this letter agreement is to document the compensation you will receive for your next two years of service as a member of the Board of Directors (the ?Board?) of Blend Labs, Inc. (?Blend? or the ?Company?). We appreciate your valuable contributions as a member of the Board |
|
| June 21, 2021 |
Blend Labs, Inc. 2012 Stock Plan and related form agreements. Exhibit 10.3 BLEND LABS, INC. 2012 STOCK PLAN ADOPTED ON MAY 1, 2012 AMENDED ON JUNE 16, 2021 TABLE OF CONTENTS Page SECTION 1. ESTABLISHMENT AND PURPOSE 1 SECTION 2. ADMINISTRATION 1 (a) Committees of the Board of Directors 1 (b) Authority of the Board of Directors 1 SECTION 3. ELIGIBILITY 1 (a) General Rule 1 (b) Ten-Percent Stockholders 1 SECTION 4. STOCK SUBJECT TO PLAN 2 (a) Basic Limitation |
|
| June 21, 2021 |
List of subsidiaries of the registrant. EX-21.1 12 d162671dex211.htm EX-21.1 Exhibit 21.1 SUBSIDIARIES OF BLEND LABS, INC. Subsidiary Jurisdiction Blend Brokerage, Inc. dba Blend Realty Delaware Blend Title Insurance Agency, Inc. Delaware Blend Insurance Agency, Inc. Delaware Blend Operations, Inc. Delaware Blend Insights, Inc. Delaware Blend Title of Utah, LLC Utah Blend Title Company Inc. California |
|
| June 21, 2021 |
Amended and Restated Bylaws of the registrant, as amended, as currently in effect. Exhibit 3.3 BYLAWS OF BLEND LABS, INC. (A DELAWARE CORPORATION) TABLE OF CONTENTS Page ARTICLE I OFFICES 1 1.1 Registered Office 1 1.2 Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 2.1 Location 1 2.2 Timing 1 2.3 Notice of Meeting 1 2.4 Stockholders? Records 1 2.5 Special Meetings 2 2.6 Notice of Meeting 2 2.7 Business Transacted at Special Meeting 2 2.8 Quorum; Meeting Adjournment; Presence by |
|
| June 21, 2021 |
EXECUTION VERSION Exhibit 2.1 STOCK PURCHASE AGREEMENT by and among TITLE365 HOLDING CO., XOME HOLDINGS LLC, BLEND LABS, INC. and solely for the purposes of Section 4.02, Section 4.04, Section 6.06, Section 6.11 and Section 11.13 of this Agreement, MR. COOPER GROUP INC. Dated as of March 12, 2021 TABLE OF CONTENTS Page ARTICLE 1. DEFINITIONS 2 Section 1.01 Definitions 2 Section 1.02 Cross-Referenc |
|
| June 21, 2021 |
Offer Letter between the registrant and Roger W. Ferguson, dated as of March 29, 2021. Exhibit 10.13 BLEND LABS, INC. March 29, 2021 Roger Ferguson Re: Board of Directors of Blend Labs, Inc. Dear Roger: As we have discussed, we expect that you will be elected as a member of the Board of Directors (the ?Board?) of Blend Labs, Inc. (?Blend? or the ?Company?). We appreciate your willingness to accept this position, and we look forward to your valuable contributions. As you may be aware |
|
| June 21, 2021 |
Outside Director Compensation Policy. Exhibit 10.7 BLEND LABS, INC. OUTSIDE DIRECTOR COMPENSATION POLICY Adopted and approved June 16, 2021 Blend Labs, Inc. (the ?Company?) believes that the granting of compensation to its members of the Board of Directors (the ?Board,? and members of the Board, the ?Directors?) represents an effective tool to attract, retain, and reward Directors who are not employees of the Company (the ?Outside Dir |
|
| June 21, 2021 |
Table of Contents As filed with the Securities and Exchange Commission on June 21, 2021. |
|
| June 21, 2021 |
Exhibit 10.4 2020 Executive Bonus Plan Plan Effective Date This Incentive Compensation Plan (the ?Plan?) is effective during the 2020 plan year beginning on January 1, 2020 and expected to end December 31, 2020 unless other events occur outlined in the ?liquidity event? section of this Agreement. Subsequent Terms This Plan is designed to reward contributions to company performance over a period of |
|
| June 21, 2021 |
Office Lease between the registrant and 500 Pine Street Company LLC, dated as of December 1, 2016. Exhibit 10.17 OFFICE LEASE 500 PINE STREET 500 PINE STREET COMPANY LLC, a Delaware limited liability company, as Landlord, and BLEND LABS, INC., a Delaware corporation as Tenant. TABLE OF CONTENTS Page 1. PREMISES, BUILDING, PROJECT, AND COMMON AREAS 1 2. LEASE TERM; OPTION TERM 2 3. BASE RENT; RENT ABATEMENT 6 4. ADDITIONAL RENT 7 5. USE OF PREMISES 14 6. SERVICES AND UTILITIES 15 7. REPAIRS 18 8 |
|
| June 21, 2021 |
Wilson Sonsini Goodrich & Rosati Professional Corporation 650 Page Mill Road Palo Alto, California 94304-1050 O: 650. |
|
| May 28, 2021 |
Wilson Sonsini Goodrich & Rosati Professional Corporation 650 Page Mill Road Palo Alto, California 94304-1050 O: 650. |
|
| May 28, 2021 |
Table of Contents As confidentially submitted to the Securities and Exchange Commission on May 28, 2021. |
|
| April 15, 2021 |
DRS 1 filename1.htm Table of Contents As confidentially submitted to the Securities and Exchange Commission on April 15, 2021. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGIST |
|
| April 15, 2021 |
BLEND LABS, INC. March 29, 2021 EX-10.5 4 filename4.htm Exhibit 10.5 BLEND LABS, INC. March 29, 2021 Erin Collard Re: Board of Directors of Blend Labs, Inc. Dear Erin: The purpose of this letter agreement is to document the compensation you will receive for your next two years of service as a member of the Board of Directors (the “Board”) of Blend Labs, Inc. (“Blend” or the “Company”). We appreciate your valuable contributions a |
|
| April 15, 2021 |
Exhibit 10.7 OFFICE LEASE 500 PINE STREET 500 PINE STREET COMPANY LLC, a Delaware limited liability company, as Landlord, and BLEND LABS, INC., a Delaware corporation as Tenant. TABLE OF CONTENTS Page 1. PREMISES, BUILDING, PROJECT, AND COMMON AREAS 1 2. LEASE TERM; OPTION TERM 2 3. BASE RENT; RENT ABATEMENT 6 4. ADDITIONAL RENT 7 5. USE OF PREMISES 14 6. SERVICES AND UTILITIES 15 7. REPAIRS 18 8. |
|
| April 15, 2021 |
EXECUTION VERSION Exhibit 2.1 STOCK PURCHASE AGREEMENT by and among TITLE365 HOLDING CO., XOME HOLDINGS LLC, BLEND LABS, INC. and solely for the purposes of Section 4.02, Section 4.04, Section 6.06, Section 6.11 and Section 11.13 of this Agreement, MR. COOPER GROUP INC. Dated as of March 12, 2021 TABLE OF CONTENTS Page ARTICLE 1. DEFINITIONS 2 Section 1.01 Definitions 2 Section 1.02 Cross-Referenc |
|
| April 15, 2021 |
BLEND LABS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT JANUARY 11, 2021 EX-4.2 3 filename3.htm Exhibit 4.2 BLEND LABS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT JANUARY 11, 2021 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT This AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of the 11 day of January, 2021, by and among BLEND LABS, INC., a Delaware corporation (the “Company”), and the investors listed on Schedule A hereto, |
|
| April 15, 2021 |
BLEND LABS, INC. March 29, 2021 EX-10.6 5 filename5.htm Exhibit 10.6 BLEND LABS, INC. March 29, 2021 Roger Ferguson Re: Board of Directors of Blend Labs, Inc. Dear Roger: As we have discussed, we expect that you will be elected as a member of the Board of Directors (the “Board”) of Blend Labs, Inc. (“Blend” or the “Company”). We appreciate your willingness to accept this position, and we look forward to your valuable contributio |
